Gene Therapy Market
Gene Therapy Market - Global Industry Assessment & Forecast
#
Pages:
230
Base Year:
2024
Nov - 2024
Format:
Report Code:
VMR-3387
Segments Covered
By
Vector Type Viral Vector, Non-Viral Vector
-
By
Gene Type Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth Factors, Receptors
-
By
Application Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2024 |
| Forecast
Years:
|
2025 - 2034 |
 Historical
Years:
|
2019 - 2023 |
 Revenue
2024: |
USD XX Billion |
 Revenue 2034:
|
USD XX Billion |
 Revenue CAGR
(2025 - 2034): |
30% |
Fastest Growing Region (2025 -
2034)
|
North America |
Largest Region (2024):
|
XX |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Gene Therapy Market Segment Analysis
- Gene Therapy Vector Type Outlook (Revenue, USD Million, 2018 - 2030)
- Viral Vector
- Non-Viral Vector
- Gene Therapy Gene Type Outlook (Revenue, USD Million, 2018 - 2030)
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
- Gene Therapy Application Outlook (Revenue, USD Million, 2018 - 2030)
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
-
North America Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
-
North America Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- U.S.
- U.S. Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
- U.S. Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
- U.S. Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- U.S. Gene Therapy Market, by Vector Type
- Canada
- Canada Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
- Canada Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
- Canada Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- Canada Gene Therapy Market, by Vector Type
-
Mexico
- Mexico Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
- Mexico Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
- Mexico Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- Mexico Gene Therapy Market, by Vector Type
-
North America Gene Therapy Market, by Vector Type
- Europe
-
Europe Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
-
Europe Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
-
Europe Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- U. K.
- U.K. Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
- U.K. Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
- U.K. Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- U.K. Gene Therapy Market, by Vector Type
- France
- France Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
- France Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
- France Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- France Gene Therapy Market, by Vector Type
-
Germany
- Germany Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
- Germany Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
- Germany Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- Germany Gene Therapy Market, by Vector Type
-
Italy
- Italy Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
- Italy Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
- Italy Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- Italy Gene Therapy Market, by Vector Type
-
Spain
- Spain Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
- Spain Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
- Spain Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- Spain Gene Therapy Market, by Vector Type
-
Rest of Europe
- Rest of Europe Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
- Rest of Europe Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
- Rest of Europe Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- Rest of Europe Gene Therapy Market, by Vector Type
-
Europe Gene Therapy Market, by Vector Type
- Asia Pacific
-
Asia Pacific Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
-
Asia Pacific Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
-
Asia Pacific Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- China
- China Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
- China Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
- China Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- China Gene Therapy Market, by Vector Type
- Japan
- Japan Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
- Japan Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
- Japan Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- Japan Gene Therapy Market, by Vector Type
-
Germany
- Germany Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
- Germany Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
- Germany Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- Germany Gene Therapy Market, by Vector Type
-
India
- India Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
- India Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
- India Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- India Gene Therapy Market, by Vector Type
-
South Korea
- South Korea Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
- South Korea Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
- South Korea Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- South Korea Gene Therapy Market, by Vector Type
-
South East Asia
- South East Asia Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
- South East Asia Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
- South East Asia Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- South East Asia Gene Therapy Market, by Vector Type
-
Rest of Asia Pacific
- Rest of Asia Pacific Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
- Rest of Asia Pacific Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
- Rest of Asia Pacific Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- Rest of Asia Pacific Gene Therapy Market, by Vector Type
-
Asia Pacific Gene Therapy Market, by Vector Type
- Latin America
-
Latin America Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
-
Latin America Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
-
Latin America Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- Brazil
- Brazil Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
- Brazil Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
- Brazil Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- Brazil Gene Therapy Market, by Vector Type
- Argentina
- Argentina Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
- Argentina Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
- Argentina Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- Argentina Gene Therapy Market, by Vector Type
-
Rest of Latin America
- Rest of Latin America Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
- Rest of Latin America Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
- Rest of Latin America Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- Rest of Latin America Gene Therapy Market, by Vector Type
-
Latin America Gene Therapy Market, by Vector Type
- Middle East & Africa
-
Middle East & Africa Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
-
Middle East & Africa Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
-
Middle East & Africa Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- GCC Countries
- GCC Countries Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
- GCC Countries Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
- GCC Countries Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- GCC Countries Gene Therapy Market, by Vector Type
- South Africa
- South Africa Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
- South Africa Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
- South Africa Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- South Africa Gene Therapy Market, by Vector Type
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Gene Therapy Market, by Vector Type
- Viral Vector
- Non-Viral Vector
- Rest of Middle East & Africa Gene Therapy Market, by Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth Factors
- Receptors
- Rest of Middle East & Africa Gene Therapy Market, by Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- Rest of Middle East & Africa Gene Therapy Market, by Vector Type
-
Middle East & Africa Gene Therapy Market, by Vector Type
- North America
FAQ
Frequently Asked Question
What is the global demand for Gene Therapy in terms of revenue?
-
The global Gene Therapy valued at USD XX Billion in 2024 and is expected to reach USD XX Billion in 2034 growing at a CAGR of 30%.
Which are the prominent players in the market?
-
The prominent players in the market are Adaptimmune Therapeutics Plc., Anchiano Therapeutics Ltd., Achieve Life Sciences, Inc., Adverum Biotechnologies, Inc., Abeona Therapeutics Inc., Applied Genetic Technologies Corporation, Arbutus Biopharma Corporation, Audentes Therapeutics, Inc., AveXis, Inc., Bluebird Bio, Inc., Celgene Corporation, CRISPR Therapeutics AG, Editas Medicine, Inc., Editas Medicine, Inc., GlaxoSmithKline Plc., Intellia Therapeutics, Inc., Merck & Co., Inc., Novartis AG, REGENXBIO Inc., Spark Therapeutics, Inc., Sangamo Therapeutics, Inc., Uniqure N. V., Voyager Therapeutics, Inc. .
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 30% between 2025 and 2034.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Gene Therapy include
Which region accounted for the largest share in the market?
-
XX was the leading regional segment of the Gene Therapy in 2024.
